118 related articles for article (PubMed ID: 37971370)
21. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study.
Rapiti E; Pinaud K; Chappuis PO; Viassolo V; Ayme A; Neyroud-Caspar I; Usel M; Bouchardy C
Cancer Med; 2017 Mar; 6(3):526-536. PubMed ID: 28211614
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.
Greenup R; Buchanan A; Lorizio W; Rhoads K; Chan S; Leedom T; King R; McLennan J; Crawford B; Kelly Marcom P; Shelley Hwang E
Ann Surg Oncol; 2013 Oct; 20(10):3254-8. PubMed ID: 23975317
[TBL] [Abstract][Full Text] [Related]
23. Mapping child maltreatment risk: a 12-year spatio-temporal analysis of neighborhood influences.
Gracia E; López-Quílez A; Marco M; Lila M
Int J Health Geogr; 2017 Oct; 16(1):38. PubMed ID: 29047364
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.
Acevedo F; Walbaum B; Medina L; Merino T; Camus M; Puschel K; Ramírez K; Manzor M; Veglia P; Martinez R; Guerra C; Navarro M; Bauerle C; Dominguez F; Sánchez C
Breast Cancer Res Treat; 2023 Jan; 197(2):449-459. PubMed ID: 36414796
[TBL] [Abstract][Full Text] [Related]
25. Neighborhood Disadvantage, African Genetic Ancestry, Cancer Subtype, and Mortality Among Breast Cancer Survivors.
Iyer HS; Zeinomar N; Omilian AR; Perlstein M; Davis MB; Omene CO; Pawlish K; Demissie K; Hong CC; Yao S; Ambrosone CB; Bandera EV; Qin B
JAMA Netw Open; 2023 Aug; 6(8):e2331295. PubMed ID: 37647068
[TBL] [Abstract][Full Text] [Related]
26. Are there differences in outcomes by race among women with metastatic triple-negative breast cancer?
Oppong BA; Rolle AA; Ndumele A; Li Y; Fisher JL; Bhattacharyya O; Adeyanju T; Paskett ED
Breast Cancer Res Treat; 2022 Nov; 196(2):399-408. PubMed ID: 36152139
[TBL] [Abstract][Full Text] [Related]
27. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.
Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406
[TBL] [Abstract][Full Text] [Related]
28. Triple-Negative Breast Cancer: A Comparison of Race and Survival.
Doepker MP; Holt SD; Durkin MW; Chu CH; Nottingham JM
Am Surg; 2018 Jun; 84(6):881-888. PubMed ID: 29981619
[TBL] [Abstract][Full Text] [Related]
29. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
[TBL] [Abstract][Full Text] [Related]
30. The geography of recreational open space: influence of neighborhood racial composition and neighborhood poverty.
Duncan DT; Kawachi I; White K; Williams DR
J Urban Health; 2013 Aug; 90(4):618-31. PubMed ID: 23099625
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
[TBL] [Abstract][Full Text] [Related]
32. Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database.
Plasilova ML; Hayse B; Killelea BK; Horowitz NR; Chagpar AB; Lannin DR
Medicine (Baltimore); 2016 Aug; 95(35):e4614. PubMed ID: 27583878
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for breast cancer subtypes among Black women undergoing screening mammography.
Friebel-Klingner TM; Ehsan S; Conant EF; Kontos D; Domchek SM; McCarthy AM
Breast Cancer Res Treat; 2021 Oct; 189(3):827-835. PubMed ID: 34342765
[TBL] [Abstract][Full Text] [Related]
34. Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience.
Der EM; Gyasi RK; Tettey Y; Edusei L; Bayor MT; Jiagge E; Gyakobo M; Merajver SD; Newman LA
Breast J; 2015; 21(6):627-33. PubMed ID: 26547900
[TBL] [Abstract][Full Text] [Related]
35. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
[TBL] [Abstract][Full Text] [Related]
36. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
37. Geo-spatial risk factor analysis for drug overdose death in South Florida from 2014 to 2019, and the independent contribution of social determinants of health.
Liu M; Caplan JM; Kennedy LW; Moise IK; Feaster DJ; Horigian VE; Roll JM; McPherson SM; Rao JS
Drug Alcohol Depend; 2023 Jul; 248():109931. PubMed ID: 37224675
[TBL] [Abstract][Full Text] [Related]
38. Geo-demographics of gunshot wound injuries in Miami-Dade county, 2002-2012.
Zebib L; Stoler J; Zakrison TL
BMC Public Health; 2017 Feb; 17(1):174. PubMed ID: 28178967
[TBL] [Abstract][Full Text] [Related]
39. A clinicopathological study of triple-negative breast carcinoma in a patient cohort from a tertiary care center in Sri Lanka.
Wijesinghe HD; Fernando J; Senarath U; Wijesinghe GK; S Lokuhetty MD
Indian J Pathol Microbiol; 2020; 63(3):388-396. PubMed ID: 32769327
[TBL] [Abstract][Full Text] [Related]
40. Modeling Pediatric Body Mass Index and Neighborhood Environment at Different Spatial Scales.
Grant LP; Gennings C; Wickham EP; Chapman D; Sun S; Wheeler DC
Int J Environ Res Public Health; 2018 Mar; 15(3):. PubMed ID: 29518029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
